by
Ipshita Chakraborty, Business Development Manager,
MILabs | March 12, 2014
http://www.nki.nl/
About Mouse Clinic for Cancer and Aging research (MCCA)
The ageing population in developed countries leads to rapid increase in cancer incidence and other aging-related disorders. To accelerate cancer and aging research and to contribute to the theme of 'healthy aging', the Netherlands Cancer Institute (NKI) and the European Research Institute for the Biology of Aging (ERIBA) have established a Mouse Clinic for Cancer and Aging research (MCCA). The MCCA will accelerate development of realistic mouse models that may be used for developing new therapies against cancer and aging-related diseases. In 2012, the NKI and ERIBA received an 18.6M€ subsidy from the National Roadmap for Large-Scale Research Facilities of the Netherlands Organization for Scientific Research (NWO) to upgrade and expand the MCCA.
http://www.mccanet.nl/
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About MILabs
MILabs provides high-end preclinical molecular imaging solutions (SPECT/PET/CT/MR) for biomedical and pharmaceutical research. Today these systems contribute worldwide to the development of new diagnostic solutions and therapies for diseases such as cancer, cardiac and neurodegenerative diseases, depression and diabetes. U-SPECT+/CT provides the fastest, most sensitive and highest resolution small-animal SPECT currently available. Recently MILabs introduced VECTor+ and VECTor+/CT providing extremely user friendly, fully integrated and simultaneous ultra-high resolution SPECT/PET. In collaboration with RS2D, MILabs has also introduced MR+, a dedicated, integrated preclinical MRI systems at clinical field strengths.
www.milabs.com
Back to HCB News
